These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. In vitro pharmacodynamic properties of colistin methanesulfonate and amikacin against Pseudomonas aeruginosa. Bozkurt-Guzel C, Gerceker AA. Indian J Med Microbiol; 2012; 30(1):34-8. PubMed ID: 22361758 [Abstract] [Full Text] [Related]
8. CSA-131, a ceragenin active against colistin-resistant Acinetobacter baumannii and Pseudomonas aeruginosa clinical isolates. Vila-Farrés X, Callarisa AE, Gu X, Savage PB, Giralt E, Vila J. Int J Antimicrob Agents; 2015 Nov; 46(5):568-71. PubMed ID: 26395218 [Abstract] [Full Text] [Related]
10. Rhesus θ-defensin-1 (RTD-1) exhibits in vitro and in vivo activity against cystic fibrosis strains of Pseudomonas aeruginosa. Beringer PM, Bensman TJ, Ho H, Agnello M, Denovel N, Nguyen A, Wong-Beringer A, She R, Tran DQ, Moskowitz SM, Selsted ME. J Antimicrob Chemother; 2016 Jan; 71(1):181-8. PubMed ID: 26433781 [Abstract] [Full Text] [Related]
11. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units. Timurkaynak F, Can F, Azap OK, Demirbilek M, Arslan H, Karaman SO. Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562 [Abstract] [Full Text] [Related]
13. Synergistic killing of multidrug-resistant Pseudomonas aeruginosa at multiple inocula by colistin combined with doripenem in an in vitro pharmacokinetic/pharmacodynamic model. Bergen PJ, Tsuji BT, Bulitta JB, Forrest A, Jacob J, Sidjabat HE, Paterson DL, Nation RL, Li J. Antimicrob Agents Chemother; 2011 Dec; 55(12):5685-95. PubMed ID: 21911563 [Abstract] [Full Text] [Related]
17. In vitro activity of the aerosolized agents colistin and tobramycin and five intravenous agents against Pseudomonas aeruginosa isolated from cystic fibrosis patients in southwestern Germany. Schülin T. J Antimicrob Chemother; 2002 Feb; 49(2):403-6. PubMed ID: 11815589 [Abstract] [Full Text] [Related]
18. In vitro efficacy of colistin against multi-drug resistant Pseudomonas aeruginosa by minimum inhibitory concentration. Gill MM, Rao JU, Kaleem F, Hassan A, Khalid A, Anjum R. Pak J Pharm Sci; 2013 Jan; 26(1):7-10. PubMed ID: 23261721 [Abstract] [Full Text] [Related]
19. Activity of colistin combined with doripenem at clinically relevant concentrations against multidrug-resistant Pseudomonas aeruginosa in an in vitro dynamic biofilm model. Lora-Tamayo J, Murillo O, Bergen PJ, Nation RL, Poudyal A, Luo X, Yu HY, Ariza J, Li J. J Antimicrob Chemother; 2014 Sep; 69(9):2434-42. PubMed ID: 24833752 [Abstract] [Full Text] [Related]
20. Clinically relevant plasma concentrations of colistin in combination with imipenem enhance pharmacodynamic activity against multidrug-resistant Pseudomonas aeruginosa at multiple inocula. Bergen PJ, Forrest A, Bulitta JB, Tsuji BT, Sidjabat HE, Paterson DL, Li J, Nation RL. Antimicrob Agents Chemother; 2011 Nov; 55(11):5134-42. PubMed ID: 21876058 [Abstract] [Full Text] [Related] Page: [Next] [New Search]